CCM
DGX icon

Cadence Capital Management’s Quest Diagnostics DGX Stock Holding History

Cadence Capital Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-42,363
Closed -$2.57M – 613
2014
Q3 		$2.57M Buy
42,363
+6,658
+19% +$410K 0.14% 196
2014
Q2 		$2.1M Buy
35,705
+936
+3% +$54.8K 0.1% 303
2014
Q1 		$2.01M Sell
34,769
-11,459
-25% -$614K 0.08% 321
2013
Q4 		$2.48M Buy
+46,228
New +$2.74M 0.09% 316

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $23.3B AUM 26.95% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Cadence Capital Management's DGX Position: Q4 2014 in Review

Cadence Capital Management sold out of Quest Diagnostics (DGX) in Q4 2014, closing a stake of 42,363 shares — an estimated $2.57M sold.

Cadence Capital Management first reported a position in DGX in Q4 2013 and held it in 4 quarters. The position peaked at $2.57M in Q3 2014. 517 funds tracked by Wall St. Rank hold DGX as of Q4 2014.

  • Cadence Capital Management reported no remaining Quest Diagnostics position as of Q4 2014 after selling out during the quarter.
  • Cadence Capital Management sold 42,363 Quest Diagnostics shares in Q4 2014, an estimated $2.57M.
  • Cadence Capital Management first reported a position in Quest Diagnostics in Q4 2013 and held it in 4 quarters.
  • Cadence Capital Management's Quest Diagnostics position peaked at $2.57M in Q3 2014.
  • 517 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2014.

Based on Cadence Capital Management's 13F filing for Q4 2014, filed 3 Feb 2015.